The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patie...
Saved in:
| Published in | British journal of clinical pharmacology Vol. 74; no. 6; p. 932 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.12.2012
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patients who can be recruited in this patient group, efficient design and analysis of these studies is of special relevance. This paper is a summary of a conference session organized at the American Conference of Pharmacometrics in April 2011, around the topic of applying pharmacometric methodology to this important problem. The discussion included both design and analysis of clinical studies during pregnancy and in silico predictions. An overview of different pharmacometric methods relevant to this subject was given. The impact of pharmacometrics was illustrated using a range of case examples of studies around pregnancy. |
|---|---|
| AbstractList | Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patients who can be recruited in this patient group, efficient design and analysis of these studies is of special relevance. This paper is a summary of a conference session organized at the American Conference of Pharmacometrics in April 2011, around the topic of applying pharmacometric methodology to this important problem. The discussion included both design and analysis of clinical studies during pregnancy and in silico predictions. An overview of different pharmacometric methods relevant to this subject was given. The impact of pharmacometrics was illustrated using a range of case examples of studies around pregnancy. Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patients who can be recruited in this patient group, efficient design and analysis of these studies is of special relevance. This paper is a summary of a conference session organized at the American Conference of Pharmacometrics in April 2011, around the topic of applying pharmacometric methodology to this important problem. The discussion included both design and analysis of clinical studies during pregnancy and in silico predictions. An overview of different pharmacometric methods relevant to this subject was given. The impact of pharmacometrics was illustrated using a range of case examples of studies around pregnancy.Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patients who can be recruited in this patient group, efficient design and analysis of these studies is of special relevance. This paper is a summary of a conference session organized at the American Conference of Pharmacometrics in April 2011, around the topic of applying pharmacometric methodology to this important problem. The discussion included both design and analysis of clinical studies during pregnancy and in silico predictions. An overview of different pharmacometric methods relevant to this subject was given. The impact of pharmacometrics was illustrated using a range of case examples of studies around pregnancy. |
| Author | Mattison, Donald R van Hasselt, J G Coen Tarning, Joel Hebert, Mary F Vicini, Paolo Andrew, Marilee A |
| Author_xml | – sequence: 1 givenname: J G Coen surname: van Hasselt fullname: van Hasselt, J G Coen email: jgc.vanhasselt@gmail.com organization: Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. jgc.vanhasselt@gmail.com – sequence: 2 givenname: Marilee A surname: Andrew fullname: Andrew, Marilee A – sequence: 3 givenname: Mary F surname: Hebert fullname: Hebert, Mary F – sequence: 4 givenname: Joel surname: Tarning fullname: Tarning, Joel – sequence: 5 givenname: Paolo surname: Vicini fullname: Vicini, Paolo – sequence: 6 givenname: Donald R surname: Mattison fullname: Mattison, Donald R |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22452385$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkEtLxDAUhYOMOA_9C5LluGjNs03dDYMvGHAzrkuaJtMOTVKTFpx_b8FRxAOXe-B-9yzOEsycdxoAiFGKJ90fU0wznhBMeEoQJiliRKD08wIsfg-zP34OljEeEcIUZ_wKzAlhnFDBF6DbNxrGQQ5jhN7AvpHBSuWtHkKrImwd7IM-OOnU6QE27aHpphkiNMFbOEy_dB3qO7ixeuKlg8o7o4N2SkPv_sddg0sju6hvznsF3p8e99uXZPf2_Lrd7JIek2xIasxzJZhUUlcqJ6yoGC-QMLWpZF7VpFC5UEIYjAqmGauFUYUyuKa04pJQSldg_Z3bB_8x6jiUto1Kd5102o-xxCSnWBQIZRN6e0bHyuq67ENrZTiVPw3RL_MebUM |
| ContentType | Journal Article |
| Copyright | 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society. |
| Copyright_xml | – notice: 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/j.1365-2125.2012.04280.x |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1365-2125 |
| ExternalDocumentID | 22452385 |
| Genre | Research Support, N.I.H., Intramural Review Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Intramural NIH HHS – fundername: NICHD NIH HHS grantid: U10HD047892 – fundername: Wellcome Trust grantid: 089275 – fundername: NICHD NIH HHS grantid: U10 HD047892 |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 23N 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CGR COF CS3 CUY CVF D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS ECM EIF EJD EMOBN EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HYE HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NPM O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT 7X8 AAMMB AEFGJ AEYWJ AGXDD AGYGG AIDQK AIDYY |
| ID | FETCH-LOGICAL-p126t-d157c84acaebc7249b45908fdfba7bd29c78c88f1094e44d8fc9cf1d33b5a2333 |
| ISSN | 1365-2125 |
| IngestDate | Fri Jul 11 06:26:41 EDT 2025 Thu Apr 03 07:02:35 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p126t-d157c84acaebc7249b45908fdfba7bd29c78c88f1094e44d8fc9cf1d33b5a2333 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 22452385 |
| PQID | 1273189006 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1273189006 pubmed_primary_22452385 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-Dec 20121201 |
| PublicationDateYYYYMMDD | 2012-12-01 |
| PublicationDate_xml | – month: 12 year: 2012 text: 2012-Dec |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | British journal of clinical pharmacology |
| PublicationTitleAlternate | Br J Clin Pharmacol |
| PublicationYear | 2012 |
| References | 21722356 - Malar J. 2011;10:181 11703394 - Clin Exp Pharmacol Physiol. 2001 Nov;28(11):905-12 18559644 - Antimicrob Agents Chemother. 2008 Sep;52(9):3013-21 11814522 - Obstet Gynecol. 2002 Feb;99(2):366-8 19104028 - Antimicrob Agents Chemother. 2009 Mar;53(3):945-52 16797800 - Vaccine. 2006 Nov 10;24(44-46):6660-3 20613720 - Clin Pharmacol Ther. 2010 Aug;88(2):166-82 10934667 - J Clin Pharmacol. 2000 Aug;40(8):836-43 17053895 - Eur J Clin Pharmacol. 2006 Dec;62(12):1021-31 10636334 - Stat Methods Med Res. 1999 Sep;8(3):183-93 22246291 - Pharm Res. 2012 Jun;29(6):1609-17 12019123 - Antimicrob Agents Chemother. 2002 Jun;46(6):1993-5 18676886 - Antimicrob Agents Chemother. 2008 Oct;52(10):3687-93 5521362 - Antimicrob Agents Chemother (Bethesda). 1970;10:427-30 15370958 - Xenobiotica. 2004 May;34(5):415-27 19295505 - Clin Pharmacol Ther. 2009 Jun;85(6):607-14 19620325 - Antimicrob Agents Chemother. 2009 Oct;53(10):4368-76 15842560 - Br J Clin Pharmacol. 2005 May;59(5):598-601 19776738 - Clin Pharmacol Ther. 2010 Feb;87(2):226-34 20126256 - PLoS Med. 2010 Jan;7(1):e1000221 19163951 - Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5454-7 12392584 - Br J Clin Pharmacol. 2002 Oct;54(4):372-7 21345415 - Am J Obstet Gynecol. 2011 Jul;205(1):10-8 12708613 - Crit Rev Toxicol. 2003;33(2):137-211 17456583 - J Clin Pharmacol. 2007 Jun;47(6):689-96 11744606 - Drug Metab Dispos. 2002 Jan;30(1):13-9 7091383 - Am J Physiol. 1982 Jul;243(1):R1-6 11579439 - Med Res Rev. 2001 Sep;21(5):382-96 12955370 - Eur J Clin Pharmacol. 2003 Oct;59(7):553-7 21492826 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S84-8 21640232 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S94-5 2036746 - Clin Pharmacokinet. 1991 Apr;20(4):253-62 21492824 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S89-93 19564366 - Antimicrob Agents Chemother. 2009 Sep;53(9):3837-46 2384078 - Epilepsy Res. 1990 Apr;5(3):223-8 18074029 - PLoS One. 2007;2(12):e1305 7362796 - Br J Obstet Gynaecol. 1980 Feb;87(2):106-9 11956508 - Clin Pharmacol Ther. 2002 Apr;71(4):253-62 21785566 - J Biomed Biotechnol. 2011;2011:783528 16176115 - Clin Pharmacokinet. 2005;44(10):989-1008 16552504 - Eur J Clin Pharmacol. 2006 May;62(5):367-71 4028617 - Clin Pharmacol Ther. 1985 Sep;38(3):241-50 7459286 - Br J Obstet Gynaecol. 1981 Jan;88(1):10-7 2228814 - Health Care Women Int. 1990;11(4):423-32 16799169 - Nephrol Dial Transplant. 2006 Sep;21(9):2556-62 16940405 - Ann Pharmacother. 2006 Oct;40(10):1724-30 18524996 - J Clin Pharmacol. 2008 Aug;48(8):935-47 16157085 - Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):901-7 12910331 - Eur J Clin Pharmacol. 2003 Sep;59(5-6):411-5 4680813 - Antimicrob Agents Chemother. 1972 Jun;1(6):504-7 18288078 - Clin Pharmacol Ther. 2008 Aug;84(2):248-53 15343213 - Am J Obstet Gynecol. 2004 Aug;191(2):398-407 17329990 - Clin Pharmacol Ther. 2007 Apr;81(4):547-56 21159117 - BJOG. 2011 Jan;118(2):123-35 |
| References_xml | – reference: 18676886 - Antimicrob Agents Chemother. 2008 Oct;52(10):3687-93 – reference: 4028617 - Clin Pharmacol Ther. 1985 Sep;38(3):241-50 – reference: 19163951 - Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5454-7 – reference: 11956508 - Clin Pharmacol Ther. 2002 Apr;71(4):253-62 – reference: 11579439 - Med Res Rev. 2001 Sep;21(5):382-96 – reference: 16157085 - Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):901-7 – reference: 20613720 - Clin Pharmacol Ther. 2010 Aug;88(2):166-82 – reference: 10934667 - J Clin Pharmacol. 2000 Aug;40(8):836-43 – reference: 16797800 - Vaccine. 2006 Nov 10;24(44-46):6660-3 – reference: 5521362 - Antimicrob Agents Chemother (Bethesda). 1970;10:427-30 – reference: 18524996 - J Clin Pharmacol. 2008 Aug;48(8):935-47 – reference: 2228814 - Health Care Women Int. 1990;11(4):423-32 – reference: 11814522 - Obstet Gynecol. 2002 Feb;99(2):366-8 – reference: 15370958 - Xenobiotica. 2004 May;34(5):415-27 – reference: 15343213 - Am J Obstet Gynecol. 2004 Aug;191(2):398-407 – reference: 16552504 - Eur J Clin Pharmacol. 2006 May;62(5):367-71 – reference: 12392584 - Br J Clin Pharmacol. 2002 Oct;54(4):372-7 – reference: 2036746 - Clin Pharmacokinet. 1991 Apr;20(4):253-62 – reference: 10636334 - Stat Methods Med Res. 1999 Sep;8(3):183-93 – reference: 21785566 - J Biomed Biotechnol. 2011;2011:783528 – reference: 7459286 - Br J Obstet Gynaecol. 1981 Jan;88(1):10-7 – reference: 17456583 - J Clin Pharmacol. 2007 Jun;47(6):689-96 – reference: 12910331 - Eur J Clin Pharmacol. 2003 Sep;59(5-6):411-5 – reference: 21492826 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S84-8 – reference: 21722356 - Malar J. 2011;10:181 – reference: 7091383 - Am J Physiol. 1982 Jul;243(1):R1-6 – reference: 19564366 - Antimicrob Agents Chemother. 2009 Sep;53(9):3837-46 – reference: 18559644 - Antimicrob Agents Chemother. 2008 Sep;52(9):3013-21 – reference: 19776738 - Clin Pharmacol Ther. 2010 Feb;87(2):226-34 – reference: 4680813 - Antimicrob Agents Chemother. 1972 Jun;1(6):504-7 – reference: 16176115 - Clin Pharmacokinet. 2005;44(10):989-1008 – reference: 16799169 - Nephrol Dial Transplant. 2006 Sep;21(9):2556-62 – reference: 12708613 - Crit Rev Toxicol. 2003;33(2):137-211 – reference: 21345415 - Am J Obstet Gynecol. 2011 Jul;205(1):10-8 – reference: 11744606 - Drug Metab Dispos. 2002 Jan;30(1):13-9 – reference: 11703394 - Clin Exp Pharmacol Physiol. 2001 Nov;28(11):905-12 – reference: 19620325 - Antimicrob Agents Chemother. 2009 Oct;53(10):4368-76 – reference: 12955370 - Eur J Clin Pharmacol. 2003 Oct;59(7):553-7 – reference: 2384078 - Epilepsy Res. 1990 Apr;5(3):223-8 – reference: 22246291 - Pharm Res. 2012 Jun;29(6):1609-17 – reference: 15842560 - Br J Clin Pharmacol. 2005 May;59(5):598-601 – reference: 21159117 - BJOG. 2011 Jan;118(2):123-35 – reference: 18074029 - PLoS One. 2007;2(12):e1305 – reference: 17053895 - Eur J Clin Pharmacol. 2006 Dec;62(12):1021-31 – reference: 12019123 - Antimicrob Agents Chemother. 2002 Jun;46(6):1993-5 – reference: 19295505 - Clin Pharmacol Ther. 2009 Jun;85(6):607-14 – reference: 7362796 - Br J Obstet Gynaecol. 1980 Feb;87(2):106-9 – reference: 21640232 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S94-5 – reference: 21492824 - Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S89-93 – reference: 17329990 - Clin Pharmacol Ther. 2007 Apr;81(4):547-56 – reference: 18288078 - Clin Pharmacol Ther. 2008 Aug;84(2):248-53 – reference: 19104028 - Antimicrob Agents Chemother. 2009 Mar;53(3):945-52 – reference: 20126256 - PLoS Med. 2010 Jan;7(1):e1000221 – reference: 16940405 - Ann Pharmacother. 2006 Oct;40(10):1724-30 |
| SSID | ssj0013165 |
| Score | 2.1862712 |
| SecondaryResourceType | review_article |
| Snippet | Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 932 |
| SubjectTerms | Biomedical Research - methods Biomedical Research - standards Clinical Trials as Topic Computer Simulation Drug-Related Side Effects and Adverse Reactions Female Humans Maternal-Fetal Exchange - drug effects Models, Biological Pharmacokinetics Pharmacology Pregnancy Research Design - standards |
| Title | The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22452385 https://www.proquest.com/docview/1273189006 |
| Volume | 74 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbb9NJLSd9JmqJCCS2Ng_WwLeVW-tq2tOSwgdwWSZZKYeM1-zgkP6W_tiPLtpwlC20vxlggg-djPKP5vhmEXqWpMkbnZeJyqxJOyzxREDZAIGesn_XCRKN6__4jH5_zrxfZxWj0e8BaWq_0ibm-VVfyP1aFZ2BXr5L9B8v2m8IDuAf7whUsDNe_trFXBK0bPkbddqG-9EOyTOCHL-xP31GjaevkOxPPfC6-jKISBgGmJ7fLWLoxvQbQFxI2Nr1RA277IQ2aT_Q6yzp2xO7P7L1Sagyxup2F-sfbz-CNohItUCtb_RD4KhuPWcdWR2nRVSQjT8KxTqgCtNz_9gSD0AEbxAav21DtSFBAd245DO9p4Tf0sTIciG73_d1unrhHT3xSmAZO6AAS9WWDCeoLzywMDdrou90t3UF3KaQgfjrGhy_fYoWK5NlNZtitr_XNptuNtucwTSwz2UX32yQEvwuIeoBGtnqIjs6Cza6O8SSK8pbH-AifDaz5CM1gGQfY4bnDGwjBvyrcw-4UR9BhDzoMoMPs9aJ8gzvA4Qg4PK82t3uMzj99nLwfJ-3QjqQmNF8lJckKI7gyympTQHKveSZT4UqnVaFLKk0hjBCOpJJbzkvhjDSOlIzpTFHG2BO0U80r-wxh4ZTThVSUaMfz1CrHqRLEcs1TWRK5h152H3QKTtFXulRl5-vllICTIULCH2UPPQ1felqH7i3Tzhz7W1cO0L0I0-doZ7VY20MIPVf6RYOBPyKhhY8 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+status+of+pharmacometrics+in+pregnancy%3A+highlights+from+the+3%28rd%29+American+conference+on+pharmacometrics&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=van+Hasselt%2C+J+G+Coen&rft.au=Andrew%2C+Marilee+A&rft.au=Hebert%2C+Mary+F&rft.au=Tarning%2C+Joel&rft.date=2012-12-01&rft.eissn=1365-2125&rft.volume=74&rft.issue=6&rft.spage=932&rft_id=info:doi/10.1111%2Fj.1365-2125.2012.04280.x&rft_id=info%3Apmid%2F22452385&rft.externalDocID=22452385 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-2125&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-2125&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-2125&client=summon |